You are currently on the new version of our website. Access the old version .

45 Results Found

  • Article
  • Open Access
61 Citations
9,755 Views
20 Pages

Diagnostic Significance of Selected Serum Inflammatory Markers in Women with Advanced Endometriosis

  • Izabela Kokot,
  • Agnieszka Piwowar,
  • Marcin Jędryka,
  • Katarzyna Sołkiewicz and
  • Ewa Maria Kratz

25 February 2021

Endometriosis is a gynecological disease, the pathogenesis of which seems to be directly associated with inflammatory processes. Serum concentrations of IL-1β, IL-6, hs-CRP, IgG, YKL 40 and PRL, in comparison to the well-known CA 125 levels, were stu...

  • Review
  • Open Access
40 Citations
10,809 Views
16 Pages

Serum Biomarkers for Early Detection of Gynecologic Cancers

  • Yutaka Ueda,
  • Takayuki Enomoto,
  • Toshihiro Kimura,
  • Takashi Miyatake,
  • Kiyoshi Yoshino,
  • Masami Fujita and
  • Tadashi Kimura

14 June 2010

Ovarian, endometrial, and cervical cancers are three of the most common malignancies of the female reproductive organs. CA 125, historically the most reliable serum marker for ovarian cancer, is elevated in 50% of early-stage ovarian tumors. For endo...

  • Article
  • Open Access
1 Citations
2,275 Views
12 Pages

The 28-days-to-diagnosis pathway is the current expected standard of care for women with symptoms of ovarian cancer in the UK. However, the anticipated conversion rate of symptoms to cancer is only 3%, and use of the pathway is increasing. A rapid tr...

  • Article
  • Open Access
13 Citations
3,687 Views
15 Pages

Diagnostic Added-Value of Serum CA-125 on the IOTA Simple Rules and Derivation of Practical Combined Prediction Models (IOTA SR X CA-125)

  • Phichayut Phinyo,
  • Jayanton Patumanond,
  • Panprapha Saenrungmuaeng,
  • Watcharin Chirdchim,
  • Tanyong Pipanmekaporn,
  • Apichat Tantraworasin,
  • Theera Tongsong and
  • Charuwan Tantipalakorn

Background: This study aimed to evaluate the diagnostic added-value of serum CA-125 to the International Ovarian Tumor Analysis (IOTA) Simple Rules in order to facilitate differentiation between malignant and benign ovarian tumors before surgery. Met...

  • Review
  • Open Access
12 Citations
8,219 Views
12 Pages

Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure

  • Mihai Cristian Marinescu,
  • Violeta Diana Oprea,
  • Sorina Nicoleta Munteanu,
  • Aurel Nechita,
  • Dana Tutunaru,
  • Luiza Camelia Nechita and
  • Aurelia Romila

Background: Heart failure is a global major healthcare problem with millions of hospitalizations annually and with a very high mortality. There is an increased interest in finding new and reliable biomarkers for the diagnostic, prognostic and therape...

  • Article
  • Open Access
15 Citations
4,390 Views
18 Pages

A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer

  • Diana Cviič,
  • Kiran Jagarlamudi,
  • Leon Meglič,
  • Erik Škof,
  • Andrej Zore,
  • David Lukanović,
  • Staffan Eriksson and
  • Joško Osredkar

3 March 2023

Background: The early detection of ovarian cancer is presently not effective, and it is crucial to establish biomarkers for the early diagnosis of ovarian cancer to improve the survival of patients. Materials and methods: The aim of this study was to...

  • Article
  • Open Access
187 Views
14 Pages

The Significance of Serum CA-125 Level on the Live Birth Rates of In Vitro Fertilisation in Women with Endometriosis

  • Hoi Ki Chung,
  • Shui Fan Lai,
  • Rebecca Siu Fan Wan,
  • Jennifer Ka Yee Ko,
  • Ernest Hung Yu Ng and
  • Raymond Hang Wun Li

26 December 2025

Background and Objectives: To evaluate the significance of serum CA-125 level on the live birth rate of in vitro fertilization (IVF) in women with endometriosis. Materials and Methods: This retrospective observational study included women with endome...

  • Brief Report
  • Open Access
9 Citations
2,709 Views
7 Pages

Utility of Comprehensive Serum Glycopeptide Spectra Analysis (CSGSA) for the Detection of Early Stage Epithelial Ovarian Cancer

  • Koji Matsuo,
  • Kazuhiro Tanabe,
  • Masaru Hayashi,
  • Masae Ikeda,
  • Miwa Yasaka,
  • Hiroko Machida,
  • Masako Shida,
  • Kenji Sato,
  • Hiroshi Yoshida and
  • Takeshi Hirasawa
  • + 2 authors

21 August 2020

Comprehensive serum glycopeptide spectra analysis (CSGSA) evaluates >10,000 serum glycopeptides and identifies unique glycopeptide peaks and patterns via supervised orthogonal partial least-squares discriminant modeling. CSGSA was more accurate th...

  • Article
  • Open Access
1 Citations
2,147 Views
12 Pages

Diagnostic Clues for Women with Acute Surgical Abdomen Associated with Ruptured Endometrioma

  • Jihyun Keum,
  • Won Moo Lee,
  • Joong Sub Choi,
  • Jaeman Bae,
  • Seongsil Cho and
  • Bo Kyeong Kang

2 August 2023

(1) Background: An investigation of the preoperative diagnostic clues used to identify ruptured endometrioma by comparing the ruptured and unruptured states in patients who underwent laparoscopic operations due to endometrioma. (2) Methods: Patients...

  • Article
  • Open Access
13 Citations
5,412 Views
24 Pages

Magnesium Status and Calcium/Magnesium Ratios in a Series of Cystic Fibrosis Patients

  • Marlene Fabiola Escobedo-Monge,
  • Enrique Barrado,
  • Joaquín Parodi-Román,
  • María Antonieta Escobedo-Monge,
  • Marianela Marcos-Temprano and
  • José Manuel Marugán-Miguelsanz

25 April 2022

Magnesium (Mg) is an essential micronutrient that participates in various enzymatic reactions that regulate vital biological functions. The main aim was to assess the Mg status and its association with nutritional indicators in seventeen cystic fibro...

  • Review
  • Open Access
119 Citations
10,198 Views
14 Pages

Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease for a multitude of reasons including very late diagnosis. This in part is due to the lack of understanding of the biological behavior of PDAC and the ineffective screening for this di...

  • Article
  • Open Access
1 Citations
1,947 Views
11 Pages

Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies

  • Lars Schröder,
  • Christian M. Domroese,
  • Alexander B. A. Rupp,
  • Kathrin M. E. Gihr,
  • Christoph Niederau,
  • Michael R. Mallmann and
  • Stefan Holdenrieder

Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Objective: The current study aimed to investigate whether cancer antigen 125 (CA-125), tissue polypeptide antigen (TPA) or the combination of both marker...

  • Article
  • Open Access
33 Citations
7,969 Views
15 Pages

Expression and Diagnostic Value of HE4 in Pancreatic Adenocarcinoma

  • Tianhe Huang,
  • Shi-Wen Jiang,
  • Liangyi Qin,
  • Christopher Senkowski,
  • Christian Lyle,
  • Karen Terry,
  • Steven Brower,
  • Haibin Chen,
  • Wayne Glasgow and
  • Yongchang Wei
  • + 1 author

29 January 2015

Human epididymis protein 4 (HE4) is a recognized biomarker in ovarian and endometrial cancer and over-expressed in pancreatic adenocarcinoma. The diagnostic value of HE4 in pancreatic adenocarcinoma remains unknown. Here we elucidate mRNA, protein a...

  • Article
  • Open Access
72 Citations
11,428 Views
12 Pages

27 May 2013

The aim of this study was to investigate the prognostic value of tumor markers in operable non-small cell lung cancer (NSCLC) patients. A total of 481 NSCLC patients were enrolled in the present study. High levels of neuron-specific enolase (NSE), ca...

  • Systematic Review
  • Open Access
1 Citations
1,210 Views
14 Pages

The Role of CA125 and HE4 in Uterine Sarcomas: Beyond Diagnosis and Prognosis—A Systematic Review and Case Series from a Single Institution

  • Gianna Barbara Cundari,
  • Laura Feole,
  • Corrado Terranova,
  • Carlo De Cicco Nardone,
  • Roberto Montera,
  • Daniela Luvero,
  • Federica Guzzo,
  • Arianna Martinelli,
  • Violante Di Donato and
  • Roberto Angioli
  • + 1 author

27 April 2025

Background: Serum biomarkers such as Carcinoma Antigen 125 (CA125) and Human Epididymis Protein 4 (HE4) are widely used in the diagnosis and prognosis of gynecological malignancies. Serum biomarkers such as CA125 and HE4 represent essential tools in...

  • Case Report
  • Open Access
3 Citations
3,162 Views
9 Pages

Giant Benign Struma Ovarii with High-Grade Fever, Elevated CA 125, and Hormonal Function in an Adolescent Patient

  • Ioana Anca Stefanopol,
  • Alexandru Petecariu,
  • Liliana Baroiu,
  • Anca-Iulia Neagu,
  • Roxana-Elena Bogdan-Goroftei,
  • Alexandru Nechifor,
  • Diana-Andreea Ciortea and
  • Nicolae Sarbu

Struma ovarii (SO) is a monodermal teratoma containing at least 50% thyroid tissue. Classically, SO is a hormonally inactive benign neoplasm that occurs in premenopausal women, and has unspecific clinical and imaging features. Its treatment is surgic...

  • Article
  • Open Access
66 Citations
10,802 Views
20 Pages

Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer

  • Gangping Wang,
  • Yan Qin,
  • Junxi Zhang,
  • Jinhui Zhao,
  • Yun'ai Liang,
  • Zuofeng Zhang,
  • Meihua Qin and
  • Yanqing Sun

28 May 2014

Breast cancer is the second leading cause of cancer death in women. Serum biomarkers such as cancer antigen 15-3 (CA15-3), cancer antigen 125 (CA125), and carcinoembryonic antigen (CEA) can be used as diagnostic and prognostic factors and can also pr...

  • Review
  • Open Access
41 Citations
10,627 Views
20 Pages

The Potential Role of MUC16 (CA125) Biomarker in Lung Cancer: A Magic Biomarker but with Adversity

  • Hebatallah M. Saad,
  • Ghada F. Tourky,
  • Hayder M. Al-kuraishy,
  • Ali I. Al-Gareeb,
  • Ahmed M. Khattab,
  • Sohaila A. Elmasry,
  • Abdulrahman A. Alsayegh,
  • Zaki H. Hakami,
  • Ahmad Alsulimani and
  • Jean-Marc Sabatier
  • + 5 authors

29 November 2022

Lung cancer is the second most commonly diagnosed cancer in the world. In terms of the diagnosis of lung cancer, combination carcinoembryonic antigen (CEA) and cancer antigen 125 (CA125) detection had higher sensitivity, specificity, and diagnostic o...

  • Article
  • Open Access
20 Citations
4,370 Views
8 Pages

Salvaging Detection of Early-Stage Ovarian Malignancies When CA125 Is Not Informative

  • Charles J. Dunton,
  • Megan L. Hutchcraft,
  • Rowan G. Bullock,
  • Lesley E. Northrop and
  • Frederick R. Ueland

Background: Ovarian cancer is the deadliest gynecologic cancer, with no recommended screening test to assist with early detection. Cancer antigen 125 (CA125) is a serum biomarker commonly used by clinicians to assess preoperative cancer risk, but it...

  • Article
  • Open Access
16 Citations
4,439 Views
18 Pages

17 November 2022

Early detection of endometrial cancer improves survival. Non-invasive diagnostic biomarkers would improve triage of symptomatic women for investigations. This study aimed to determine the diagnostic accuracy of serum Cancer Antigen 125 (CA125) and Hu...

  • Article
  • Open Access
206 Views
19 Pages

22 December 2025

Background: Patients with colorectal cancer (CRC) have varying responses to 5-fluorouracil (5-FU) treatment, particularly reduced-dose regimens. Inflammatory and tumor-associated serum biomarkers, such as carcinoembryonic antigen (CEA), carbohydrate...

  • Case Report
  • Open Access
3,601 Views
8 Pages

Fibrothecoma in a Virgo Intacta Adolescent with Elevated Levels of CA 125 and B-hCG: A Case Report

  • Saša Raičević,
  • Kristina Radoman,
  • Saša Radović,
  • Ljiljana Vučković and
  • Filip Vukmirović

Ovarian fibromas are benign tumors that consist of spindle cells in bundles or storiformly arranged with collagen fibers in the stroma. Thecomas resemble theca interna ovarian cells, and there is lipid material in their cytoplasm. There is an overlap...

  • Article
  • Open Access
49 Citations
9,081 Views
18 Pages

A Bead-Based Multiplexed Immunoassay to Evaluate Breast Cancer Biomarkers for Early Detection in Pre-Diagnostic Serum

  • Annemieke W. J. Opstal-van Winden,
  • Wendy Rodenburg,
  • Jeroen L. A. Pennings,
  • Conny T. M. Van Oostrom,
  • Jos H. Beijnen,
  • Petra H.M. Peeters,
  • Carla H. Van Gils and
  • Annemieke De Vries

22 October 2012

This study investigates whether a set of ten potential breast cancer serum biomarkers and cancer antigens (osteopontin (OPN), haptoglobin, cancer antigen 15-3 (CA15-3), carcinoembryonic antigen (CEA), cancer antigen 125 (CA-125), prolactin, cancer an...

  • Article
  • Open Access
6 Citations
2,823 Views
11 Pages

Comparative Analysis of Circulating Biomarkers for Patients Undergoing Resection of Colorectal Liver Metastases

  • Sven H. Loosen,
  • Christoph Roderburg,
  • Patrick H. Alizai,
  • Anjali A. Roeth,
  • Sophia M. Schmitz,
  • Mihael Vucur,
  • Mark Luedde,
  • David Schöler,
  • Pia Paffenholz and
  • Frank Tacke
  • + 4 authors

27 October 2021

Surgical tumor resection has evolved as a potentially curative therapy for patients with resectable colorectal liver metastases (CRLM). However, disease recurrence is common and the available preoperative stratification strategies are often imprecise...

  • Article
  • Open Access
5 Citations
3,293 Views
20 Pages

Automated Assay of a Four-Protein Biomarker Panel for Improved Detection of Ovarian Cancer

  • Christopher Walker,
  • Tuan-Minh Nguyen,
  • Shlomit Jessel,
  • Ayesha B. Alvero,
  • Dan-Arin Silasi,
  • Thomas Rutherford,
  • Sorin Draghici and
  • Gil Mor

17 January 2021

Background: Mortality from ovarian cancer remains high due to the lack of methods for early detection. The difficulty lies in the low prevalence of the disease necessitating a significantly high specificity and positive-predictive value (PPV) to avoi...

  • Article
  • Open Access
8 Citations
2,339 Views
11 Pages

Evaluation of the Clinical Value of KL-6 and Tumor Markers in Primary Sjögren’s Syndrome Complicated with Interstitial Lung Disease

  • Fengqin Wei,
  • Xinran Zhang,
  • Shengnan Yang,
  • Jing Geng,
  • Bingbing Xie,
  • Yanhong Ren and
  • Huaping Dai

27 July 2023

Objective: primary Sjögren’s syndrome (pSS) is an autoimmune disease, of which the most common complication is interstitial lung disease (ILD). This study aimed to analyze the clinical value of Krebs von den Lungen-6 (KL-6), carcinoembryon...

  • Article
  • Open Access
2 Citations
3,159 Views
19 Pages

Single-Cell RNA Sequencing of PBMCs Identified Junction Plakoglobin (JUP) as Stratification Biomarker for Endometriosis

  • Thomas Andrieu,
  • Angelo Duo,
  • Lea Duempelmann,
  • Magdalena Patzak,
  • Flurina Annacarina Maria Saner,
  • Jitka Skrabalova,
  • Cinzia Donato,
  • Peter Nestorov and
  • Michael D. Mueller

5 December 2024

This study aimed to identify unique characteristics in the peripheral blood mononuclear cells (PBMCs) of endometriosis patients and develop a non-invasive early diagnostic tool. Using single-cell RNA sequencing (scRNA-seq), we constructed the first s...

  • Review
  • Open Access
18 Citations
6,213 Views
11 Pages

Meigs Syndrome and Elevated CA-125: Case Report and Literature Review of an Unusual Presentation Mimicking Ovarian Cancer

  • Irene Iavarone,
  • Michela Padovano,
  • Francesca Pasanisi,
  • Luigi Della Corte,
  • Elvira La Mantia and
  • Carlo Ronsini

19 September 2023

Background and Objectives: Meigs syndrome is represented by a benign adnexal tumor, ascites, and hydrothorax. Even though the ovarian mass is often characterized by a fibroma-like origin, cancer antigen-125 (CA-125) serum levels could be elevated as...

  • Article
  • Open Access
7 Citations
2,626 Views
13 Pages

Use of Sensor Array Analysis to Detect Ovarian Cancer through Breath, Urine, and Blood: A Case-Control Study

  • Roberto Angioli,
  • Marco Santonico,
  • Giorgio Pennazza,
  • Roberto Montera,
  • Daniela Luvero,
  • Alessandra Gatti,
  • Alessandro Zompanti,
  • Panaiotis Finamore and
  • Raffaele Antonelli Incalzi

Ovarian cancer (OC) is the eighth most common cancer in women. Since screening programs do not exist, it is often diagnosed in advanced stages. Today, the detection of OC is based on clinical examination, transvaginal ultrasound (US), and serum bioma...

  • Article
  • Open Access
6 Citations
3,708 Views
13 Pages

BARD1 Autoantibody Blood Test for Early Detection of Ovarian Cancer

  • Maxim Pilyugin,
  • Magdalena Ratajska,
  • Maciej Stukan,
  • Nicole Concin,
  • Robert Zeillinger and
  • Irmgard Irminger-Finger

25 June 2021

Background: Ovarian cancer (OC) is the most lethal gynaecological cancer. It is often diagnosed at an advanced stage with poor chances for successful treatment. An accurate blood test for the early detection of OC could reduce the mortality of this d...

  • Article
  • Open Access
4 Citations
3,322 Views
15 Pages

CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer

  • Akira Ueda,
  • Satoshi Yuki,
  • Takayuki Ando,
  • Ayumu Hosokawa,
  • Naokatsu Nakada,
  • Yosuke Kito,
  • Iori Motoo,
  • Ken Ito,
  • Miho Sakumura and
  • Yurika Nakayama
  • + 7 authors

22 February 2024

Currently, no established marker exists for predicting peritoneal metastasis progression during chemotherapy, although they are major interruptive factors in sequential chemotherapy in patients with advanced gastric cancer (AGC). This multicenter ret...

  • Article
  • Open Access
1 Citations
2,678 Views
13 Pages

Ovarian cancer remains a major diagnostic and therapeutic problem in modern gynecological oncology. For this reason, research which focuses on the search for new diagnostic markers and the assessment of their possible usefulness in clinical practice...

  • Communication
  • Open Access
16 Citations
3,444 Views
12 Pages

Lung cancer is one of the malignant tumors with the highest mortality rate, and the detection of its tumor marker carcinoma antigen 125 (CA125) is significant. Here, an electrochemical immunoassay for CA125 was described. Nitrogen-doped reduced graph...

  • Review
  • Open Access
37 Citations
6,892 Views
17 Pages

Future Screening Prospects for Ovarian Cancer

  • Diana Žilovič,
  • Rūta Čiurlienė,
  • Rasa Sabaliauskaitė and
  • Sonata Jarmalaitė

30 July 2021

Current diagnostic tools used in clinical practice such as transvaginal ultrasound, CA 125, and HE4 are not sensitive and specific enough to diagnose OC in the early stages. A lack of early symptoms and an effective asymptomatic population screening...

  • Review
  • Open Access
4 Citations
6,226 Views
18 Pages

CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations

  • Lavinia Alice Bălăceanu,
  • Cristiana Grigore,
  • Ion Dina,
  • Cristian-Dorin Gurău,
  • Mara Mădălina Mihai and
  • Beatrice Bălăceanu-Gurău

11 June 2025

Background/Objectives: Carbohydrate antigen 125 (CA125) is a glycoprotein commonly overexpressed in epithelial ovarian cancer and widely recognized as a tumor marker. However, elevated CA125 levels are also observed in various non-malignant condition...

  • Article
  • Open Access
10 Citations
1,692 Views
14 Pages

6 February 2025

Homogeneous aptasensors that eliminate the need for probe labeling or immobilization hold significant potential for the rapid detection of tumor biomarkers. Herein, a homogeneous aptasensor with electrochemical (EC) and electrochemiluminescence (ECL)...

  • Article
  • Open Access
3 Citations
2,818 Views
21 Pages

Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients

  • Katarzyna Marcisz-Grzanka,
  • Beata Kotowicz,
  • Aleksandra Nowak,
  • Mariola Winiarek,
  • Malgorzata Fuksiewicz,
  • Maria Kowalska,
  • Andrzej Tysarowski,
  • Tomasz Olesinski,
  • Jakub Palucki and
  • Urszula Sulkowska
  • + 2 authors

12 February 2024

Background: Perioperative treatment is a gold standard in locally advanced gastric cancer or GEJ cancer in the Western population. Unfortunately, the response rate after neoadjuvant chemotherapy (NAC) remains limited. Moreover, there are currently no...

  • Article
  • Open Access
748 Views
14 Pages

11 October 2025

Herein, we propose an ultrasensitive electrochemical immunosensor based on glucose oxidase labeling and enzyme-catalyzed Au staining. In brief, the primary antibody (Ab1), bovine serum albumin, an antigen and then a bionanocomposite that contains a s...

  • Opinion
  • Open Access
76 Citations
14,138 Views
8 Pages

The history of biomarkers and ultrasonography dates back over more than 50 years. The present status of biomarkers used in the context of ovarian cancer is addressed. Attention is given to new interpretations of the etiology of ovarian cancer. Cancer...

  • Guidelines
  • Open Access
10 Citations
966 Views
8 Pages

1 October 2016

Background: A need for follow-up recommendations for survivors of fallopian tube, primary peritoneal, or epithelial ovarian cancer after completion of primary treatment was identified by Cancer Care Ontario’s Program in Evidence-Based Care. Methods:...

  • Review
  • Open Access
8 Citations
3,872 Views
16 Pages

Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics

  • Sourav Chakraborty,
  • Priti S. Shenoy,
  • Megha Mehrotra,
  • Pratham Phadte,
  • Prerna Singh,
  • Bharat Rekhi and
  • Pritha Ray

14 February 2023

Epithelial ovarian cancer (EOC) is the deadliest gynaecological malignancy and the eighth most prevalent cancer in women, with an abysmal mortality rate of two million worldwide. The existence of multiple overlapping symptoms with other gastrointesti...

  • Article
  • Open Access
10 Citations
3,761 Views
12 Pages

A Novel Two-Lipid Signature Is a Strong and Independent Prognostic Factor in Ovarian Cancer

  • Liina Salminen,
  • Elena Ioana Braicu,
  • Mitja Lääperi,
  • Antti Jylhä,
  • Sinikka Oksa,
  • Sakari Hietanen,
  • Jalid Sehouli,
  • Hagen Kulbe,
  • Andreas du Bois and
  • Sven Mahner
  • + 5 authors

7 April 2021

Epithelial ovarian cancer (EOC) generally responds well to oncological treatments, but the eventual development of a refractory disease is a major clinical problem. Presently, there are no prognostic blood-based biomarkers for the stratification of E...

  • Article
  • Open Access
2 Citations
3,610 Views
9 Pages

Tumor Characteristic Variations between Symptomatic and Asymptomatic Endometrial Cancer

  • Petra Vinklerová,
  • Markéta Bednaříková,
  • Luboš Minář,
  • Michal Felsinger,
  • Jitka Hausnerová,
  • Petra Ovesná and
  • Vít Weinberger

Endometrial cancer is the most common gynecologic malignancy in Europe and usually diagnosed in its initial stage owing to early symptoms of abnormal bleeding. There is no population screening for this disease, although it can sometimes be accidental...

  • Article
  • Open Access
4 Citations
2,364 Views
13 Pages

Sensitive Detection of Gynecological Cancer Recurrence Using Circulating Tumor DNA and Digital PCR: A Comparative Study with Serum Biochemical Markers

  • Nour Balasan,
  • Feras Kharrat,
  • Giovanni Di Lorenzo,
  • Emmanouil Athanasakis,
  • Anna Monica Bianco,
  • Andrea Conti,
  • Maria Teresa Di Stazio,
  • Giulia Butera,
  • Stefania Cicogna and
  • Alessandro Mangogna
  • + 3 authors

8 November 2024

Early detection of recurrences in gynecological cancers is crucial for women’s health. Circulating tumor DNA (ctDNA) analysis through liquid biopsy offers a promising approach for monitoring disease progression and identifying relapses. This st...

  • Interesting Images
  • Open Access
8 Citations
6,624 Views
5 Pages

Ovarian gynandroblastoma (GAB) is an extremely rare sex cord-stromal tumor showing morphological evidence of both female (granulosa cell tumor) and male (Sertoli–Leydig cell tumor (SLCT)) components. Almost all GAB cases have been reported in c...